Alsonex

Brisbane, Australia Founded: 2014 • Age: 12 yrs
Develops new drugs for neurodegenerative diseases through research and partnerships.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 11 Brand Intelligence

About Alsonex

Alsonex is a company based in Brisbane (Australia) founded in 2014 by Brandon D Lewis and David Groth. It operates as a B2B. Alsonex offers products and services including ALS-205. Alsonex operates in a competitive market with competitors including Biogen, Denali Therapeutics, Intra-Cellular Therapies, Amylyx Pharmaceuticals and Annexon, among others.

  • Headquarter Brisbane, Australia
  • Founders Brandon D Lewis, David Groth
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Alsonex Pty Ltd
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Alsonex

Alsonex offers a comprehensive portfolio of products and services, including ALS-205.

Product name locked
Category locked
Primary

Treatment compound for Motor Neuron Disease and other conditions.

Funding Insights of Alsonex

Premium access

Detailed funding history for Alsonex

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Alsonex

Investments
Premium access

Investment portfolio details for Alsonex

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Alsonex

Premium access

Detailed financials for Alsonex

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Alsonex Comparisons

Alsonex Primary company
Description
Develops new drugs for neurodegenerative diseases through re...
Location
Brisbane, Australia
Founded Year
2014
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Alsonex

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Alsonex

Alsonex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, Denali Therapeutics, Intra-Cellular Therapies, Amylyx Pharmaceuticals and Annexon, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Therapies for neurodegenerative and immunology disorders are developed.
Locked Locked Locked
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
Locked Locked Locked
Developer of therapeutics for psychiatric and neurologic diseases
Locked Locked Locked
Small-molecule therapeutics for neurodegenerative diseases are developed.
Locked Locked Locked
Developer of antibodies to treat complement-mediated neurodegenerative diseases
Locked Locked Locked
Biologics platform developed for intracellular delivery in rare diseases.
Premium access

Detailed competitors of Alsonex

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Alsonex

Premium access

Complete news archive for Alsonex

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alsonex

Alsonex was founded in 2014.

Alsonex is headquartered in Brisbane, Australia. It is registered at Brisbane, Queensland, Australia.

Alsonex is a biopharmaceutical company dedicated to creating innovative treatments for neurodegenerative diseases like Parkinsons, Alzheimers, Huntingtons, and Motor Neuron Disease. Founded in 2014 from research at the University of Queensland, it advances products to proof-of-concept stages and collaborates with larger firms for clinical trials. Based in Brisbane, Australia, the company focuses on drug development while sharing risks to enhance shareholder value through targeted therapies.

Alsonex's top competitors include Alector, Intra-Cellular Therapies and Entrada Therapeutics.

Alsonex offers ALS-205.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available